Download
Food Science Nutrition - 2022 - Todorovic - Creatine consumption and liver disease manifestations in individuals aged 12.pdf 561,03KB
WeightNameValue
1000 Titel
  • Creatine consumption and liver disease manifestations in individuals aged 12 years and over
1000 Autor/in
  1. Todorovic, Nikola |
  2. Korovljev, Darinka |
  3. Stajer, Valdemar |
  4. Jorga, Jagoda |
  5. Ostojic, Sergej |
1000 Erscheinungsjahr 2022
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2022-11-18
1000 Erschienen in
1000 Quellenangabe
  • 11(2):1134-1141
1000 Copyrightjahr
  • 2022
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1002/fsn3.3151 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Despite the overwhelming safety evidence concerning creatine intake in various settings, there is still incomplete information whether dietary creatine affects liver health at the population level. The main aim of this cross-sectional population-based study was to evaluate the association between creatine intake through regular diet and liver disease manifestations, including liver fibrosis and hepatic steatosis, among individuals aged 12 years and over, using open-source data from the 2017–2018 U.S. National Health and Nutrition Examination Survey (NHANES). A total of 9254 male and female participants of all ages were included in the 2017–2018 NHANES round. We extracted data from the total sample population for participants who provided dietary data for individual foods via dietary interviews and examination data from liver ultrasound transient elastography. The final study sample consisted of 5957 participants (mean age 44.7 ± 21.0 years; 50.1% women), and the mean dietary creatine intake across the study population was 0.88 ± 0.71 g/day. Liver fibrosis and cirrhosis were diagnosed in 1703 (28.7%) and 288 (4.8%) participants, respectively; hepatic steatosis was identified in 2595 (43.7%) individuals. Binary logistic regression with multivariable model adjusted for age, gender, family income to poverty ratio, body mass index, total energy intake, and alcohol consumption showed that consuming more creatine (≥2 g/day) did not significantly increase the risk of liver fibrosis (OR = 0.92, 95% CI 0.70–1.21, p = .57), cirrhosis (OR = 0.94, 95% CI 0.53–1.65, p = .82), or hepatic steatosis (OR = 0.77, 95% CI 0.59–1.02, p = .07), as compared to participants who ingested <1 g of creatine daily. Dietary exposure to creatine through a regular diet is not associated with an increase in disease manifestations in individuals 12 years and over; further research is warranted to address the effects of excessive creatine intake (≥5 g/day) through a regular diet on liver health at the population level.
1000 Sacherschließung
lokal liver fibrosis
lokal diet
lokal blood liver panel
lokal hepatic steatosis
lokal NHANES
lokal creatine
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/VG9kb3JvdmljLCBOaWtvbGE=|https://frl.publisso.de/adhoc/uri/S29yb3ZsamV2LCBEYXJpbmth|https://frl.publisso.de/adhoc/uri/U3RhamVyLCBWYWxkZW1hcg==|https://frl.publisso.de/adhoc/uri/Sm9yZ2EsIEphZ29kYQ==|https://orcid.org/0000-0002-7270-2541
1000 Label
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
  1. Creatine consumption and liver disease manifestations in individuals aged 12 years and over
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6453227.rdf
1000 Erstellt am 2023-07-19T11:05:59.982+0200
1000 Erstellt von 286
1000 beschreibt frl:6453227
1000 Bearbeitet von 286
1000 Zuletzt bearbeitet 2023-07-19T11:07:30.484+0200
1000 Objekt bearb. Wed Jul 19 11:07:05 CEST 2023
1000 Vgl. frl:6453227
1000 Oai Id
  1. oai:frl.publisso.de:frl:6453227 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source